| The challenges of pharmacokinetic variability of first-line anti-TB drugs. | Expert Rev Clin Pharmacol | 2017 Jan | 27724114 |
| Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism. | Chem Biol Interact | 2017 Aug 1 | 28619387 |
| Metallothionein protects against isoniazid-induced liver injury through theinhibition of CYP2E1-dependent oxidative and nitrosative impairment in mice. | Food Chem Toxicol | 2017 Apr | 28126494 |
| Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs. | Indian J Med Res | 2017 Apr | 28862186 |
| Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin. | Environ Toxicol Pharmacol | 2016 Sep | 27497728 |
| Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, ProtectiveEffects against Ischemia-reperfusion Injury and Drug Adverse Reactions. | Crit Rev Food Sci Nutr | 2016 Oct 2 | 25365228 |
| NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients. | Int J Tuberc Lung Dis | 2016 Oct | 27725049 |
| Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital inKorea. | Tuberc Respir Dis (Seoul) | 2016 Oct | 27790280 |
| A new strategy for strain improvement of Aurantiochytrium sp. based on heavy-ionsmutagenesis and synergistic effects of cold stress and inhibitors of enoyl-ACPreductase. | Enzyme Microb Technol | 2016 Nov | 27702480 |
| Isoniazid-resistant tuberculosis in Iran: A systematic review. | Tuberculosis (Edinb) | 2016 May | 27156625 |